United Therapeutics buy Royal Bank of Canada
Start price
30.10.25
/
50%
€388.80
Target price
30.10.26
-
Performance (%)
6.97%
Price
04.12.25
€415.90
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.97%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -1.258% | -1.258% |
| iShares Core DAX® | 0.396% | -0.010% |
| iShares Nasdaq 100 | 0.881% | -0.819% |
| iShares Nikkei 225® | 1.405% | -3.232% |
| iShares S&P 500 | 0.259% | -0.051% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
14.13%
04.12.25
04.12.25
